Be a Smart Investor
Friday, February 24, 2017
Gainers & Losers Of The Day: CEMP, IPCI, OREX, RNVA, ARGS...
Cempra Inc.'s oral Fusidic acid has met the primary endpoint in a phase III study of ABSSSI.
from RTT - Biotech http://ift.tt/2l9qRbr
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment